International Cannabrands Announces the Official Launch of ‘Baseline’ CBD


Ryan Allway

February 19th, 2020

News


LOS ANGELES, Feb. 19, 2020 /PRNewswire/ — International Cannabrands Inc. (CSE: INCB) (the ‘Company’ or ‘INCB’) announced today the official launch of its newly developed CBD brand ‘Baseline’ and related direct-to-consumer e-commerce store.

Steve Gormley, CEO of the Company commented: “International Cannabrands continues to further develop our portfolio of world-class cannabis and hemp brands, and we remain confident that consumer brands with uniquely differentiated intellectual property will hold the most value as the industry matures. This new offering expands our reach to mainstream consumers nationwide and creates the opportunity for significant earnings.”

Baseline was created as a daily supplement to naturally support the endocannabinoid system, which supports many vital functions in the body. *Each product within the line is designed to promote homeostasis through plant-based solutions and features a benefit-driven brand architecture that closely maps to the needs of today’s hyper stimulated and overly stressed consumers.

Baseline’s formulations include full-spectrum, hemp-derived CBD infused with whole plant ingredients and adaptogens. The Company believes these compounds in concert with the properties of CBD offer a unique and highly effective product.

“The market is excited about the potential of CBD, and for good reason,” commented Greg Davis, Chief Growth Officer and Head of CBD for the Company. “However guidelines around dosage, frequency, and modes of ingestion are still unclear to a majority of consumers. In response to what is missing in the category, Baseline’s brand ethos is devoted to providing simplified and effective solutions supporting a range of need states.”

International Cannabrands developed Baseline to specifically address market gaps within the crowded CBD landscape and the product line is uniquely differentiated by:

  • A Daily Supplementation Approach 

Baseline formulations are designed for daily use to naturally supplement and provide cumulative benefits. The endocannabinoid system plays a key role in regulating basic functions like stress, mood, sleep, digestion, metabolism, immunity, and inflammatory response*. The Company believes that low-dose CBD products used consistently produce both immediate and cumulative results that can help regulate this system and keep this vast range of functions in equilibrium. Users are guided toward daily supplementation in the form of consistently dosed, easily portable capsules available through monthly subscription or single purchase.

  • Need State Specific Formulations

CBD products are often marketed as a ‘cure-all’ to address a broad list of ailments or needs. Through querying various consumer segments, the Baseline team uncovered the four most common wellness-related issues, and developed formulations aimed at addressing those specific needs. Baseline is offered in four variations: Day Shift to promote energy, Fog Lifter to support focus, Ground Control to relieve stress, and REM Ritual to promote effective sleep. The range was created to help users get the most out of their day and night.

  • A Commitment to Bioavailability 

Baseline products are created through an innovative process using proprietary dry liposome preparation in which liposomal technology is used to encapsulate active ingredients and increase bioavailability. By encapsulating hemp extract rich in terpenes and CBD into liposomes, this process significantly improves the absorption of terpenes and CBD into the intestinal cells and prolongs its effect in the body.**

Baseline products undergo rigorous in-house and independent third-party lab testing, with a Certificate of Analysis provided for each batch. Additionally, the products are non-GMO and GMP Certified.

Baseline is now available for purchase at baselinecbd.co.

*The Endocannabinoid System: An Overview

Direct link: www.frontiersin.org/articles/10.3389/fnbeh.2012.00009/full

**Liposomes as Advanced Delivery Systems for Nutraceuticals

Direct link: www.ncbi.nlm.nih.gov/pmc/articles/PMC4818067/

About International Cannabrands 

International Cannabrands is a CBD and cannabis-focused brand portfolio, leveraging the potential of the plant by offering best of breed products that naturally complement today’s consumer lifestyles. The Company’s mission is to build and market a diversified portfolio of cannabis and CBD brands, with strategic manufacturing and distribution partnerships to support better EBITDA and margins. ICI markets products with THC content where that practice has been legalized at the state level through either medicinal or recreational use. ICI also markets products containing CBD in the US and internationally. The Company believes as the legal cannabis and CBD markets evolve, high-quality, unique products will increasingly capture market share and provide a valuable platform for growth.

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Disclaimer Concerning Forward-Looking Statements

Certain statements included herein constitute “forward-looking statements” relating to implied performance or acceptance of the products, within the meaning of applicable securities laws. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Additional risks and uncertainties regarding the Company are described in its publicly-available disclosure documents filed by the Company on SEDAR (www.sedar.com). The forward-looking statements contained in this news release represent the Company’s expectations as of the date of this news release, or as of the date they are otherwise stated to be made, and subsequent events may cause these expectations to change. Except as required by law, the Company does not intend, and undertakes no obligation to update any forward-looking statements to reflect, in particular, new information or future events.

International Cannabrands Contact:
Steve Gormley
Chief Executive Officer, International Cannabrands, Ltd.
12655 W Jefferson Blvd, Los Angeles, CA, 90066
Ph: +1-(323) 828-4321
[email protected]

Investor Relations Contact:
Dave Burwell
Vice President, The Howard Group
#350, 318 – 11 Avenue SE Calgary, AB T2G 0Y2
Ph: +1-(403) 221-0915
[email protected]

Media Inquiries: [email protected]

SOURCE International Cannabrands Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading